Physician profile
Sameer N Chawla
NPI 1679511661
$4,355.80
in general payments reported to CMS, 2019-2025
29 companies · $220 in 2025
The $220 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,323 · 2020: $229 · 2021: $259 · 2022: $538 · 2023: $523 · 2024: $264 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $918 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $918.34 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,206.53 | 2019-2021 | |
| Pfizer INC. | $258.49 | 2019-2024 | |
| Antares Pharma, INC. | $205.73 | 2019-2023 | Tlando, Xyosted, Nocdurna |
| Sumitomo Pharma America, INC. | $178.82 | 2023-2025 | Gemtesa |
| Urogen Pharma, INC. | $173.74 | 2021-2024 | Jelmyto |
| Janssen Biotech, INC. | $149.60 | 2019-2023 | Erleada |
| Astellas Pharma US INC | $136.64 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $122.07 | 2023 | |
| Intuitive Surgical, INC. | $114.65 | 2022 | |
| Ethicon US, LLC | $107.62 | 2019 | |
| Medtronic, INC. | $107.14 | 2025 | Altaviva |
| Urovant Sciences INC | $99.48 | 2022 | |
| Procept Biorobotics Corporation | $76.26 | 2024-2025 | Aquabeam System |
| Endo USA, INC. | $58.99 | 2024 | Xiaflex |
| Myriad Genetic Laboratories, INC. | $53.29 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $40.96 | 2020 | |
| Verity Pharmaceuticals INC. | $35.79 | 2025 | Trelstar |
| Acerus Pharmaceuticals Corporation | $33.58 | 2020-2021 | |
| Abbvie INC. | $30.18 | 2022-2025 | |
| Convatec INC. | $30.16 | 2023 | |
| Endo Pharmaceuticals INC. | $20.86 | 2023 | Xiaflex |
| Olympus America INC. | $18.09 | 2021 | |
| 180 Medical, INC. | $17.93 | 2023 | |
| Smith+Nephew, INC. | $16.96 | 2022 | |
| Quidel Corporation | $16.44 | 2019 | |
| Teleflex LLC | $14.45 | 2025 | Deknatel |
| Coopersurgical, INC. | $12.74 | 2019 | |
| Allergan, INC. | $12.04 | 2019 | |
| Clarus Therapeutics INC. | $6.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Chawla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.